TITLE

A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease

AUTHOR(S)
Rodriguez, Mariano; Salmeron, M. Dolores; Martin-Malo, Alejandro; Barbieri, Carlo; Mari, Flavio; Molina, Rafael I.; Costa, Pedro; Aljama, Pedro
PUB. DATE
January 2016
SOURCE
PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In hemodialysis patients, deviations from KDIGO recommended values of individual parameters, phosphate, calcium or parathyroid hormone (PTH), are associated with increased mortality. However, it is widely accepted that these parameters are not regulated independently of each other and that therapy aimed to correct one parameter often modifies the others. The aim of the present study is to quantify the degree of association between parameters of chronic kidney disease and mineral bone disease (CKD-MBD). Methods: Data was extracted from a cohort of 1758 adult HD patients between January 2000 and June 2013 obtaining a total of 46.141 records (10 year follow-up). We used an advanced data analysis system called Random Forest (RF) which is based on self-learning procedure with similar axioms to those utilized for the development of artificial intelligence. This new approach is particularly useful when the variables analyzed are closely dependent to each other. Results: The analysis revealed a strong association between PTH and phosphate that was superior to that of PTH and Calcium. The classical linear regression analysis between PTH and phosphate shows a correlation coefficient is 0.27, p<0.001, the possibility to predict PTH changes from phosphate modification is marginal. Alternatively, RF assumes that changes in phosphate will cause modifications in other associated variables (calcium and others) that may also affect PTH values. Using RF the correlation coefficient between changes in serum PTH and phosphate is 0.77, p<0.001; thus, the power of prediction is markedly increased. The effect of therapy on biochemical variables was also analyzed using this RF. Conclusion: Our results suggest that the analysis of the complex interactions between mineral metabolism parameters in CKD-MBD may demand a more advanced data analysis system such as RF.
ACCESSION #
112477009

 

Related Articles

  • Mineral and Bone Disorders in Patients on Dialysis: Physiology and Clinical Consequences. McCarley, Patricia B.; Arjomand, Mahiyar // Nephrology Nursing Journal;Jan/Feb2008, Vol. 35 Issue 1, p59 

    Chronic kidney disease-mineral and bone disorder (CKD-MBD) arises from a series of independent, yet interrelated, disturbances in bone and mineral metabolism. The consequences of failing to control CKD-MBD include increased mortality, cardiovascular and soft-tissue calcification, renal...

  • Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - results from a nationwide clinical audit. Kiss, István; Kiss, Zoltán; Ambrus, Csaba; Szabó, András; Szegedi, János; Balla, József; Ladányi, Erzsébet; Csiky, Botond; Árkossy, Ottó; Török, Marietta; Túri, Sándor; Kulcsár, Imre // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background: Achieving target levels of laboratory parameters of bone and mineral metabolism in chronic kidney disease (CKD) patients is important but also difficult in those living with end-stage kidney disease. This study aimed to determine if there are age-related differences in chronic kidney...

  • Hemodiyaliz Hastalarında Kemik Mineral YoÄŸunluÄŸunun DeÄŸerlendirilmesi. Özdemir, Oya; Bilgiç, Mukadder Ayşe // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;jun2010 supplement, Vol. 56, p62 

    Objective: Low bone mass in end-stage renal disease patients, especially those undergoing hemodialysis, can lead to serious health problems such as fragility fractures and may have negative impact on their quality of life. The aim of this study was to determine bone mineral density (BMD) in a...

  • Calcium balance in haemodialysis—do not lower the dialysate calcium concentration too much (con part). Drüeke, Tilman B.; Touam, Malik // Nephrology Dialysis Transplantation;Oct2009, Vol. 24 Issue 10, p2990 

    The debate on the most adequate dialysate calcium concentration for intermittent haemodialysis therapy is ongoing. There is probably no one optimal concentration. In general, one would like to maintain a neutral calcium balance in adult haemodialysis patients. However, a slightly negative...

  • Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Iimori, Soichiro; Mori, Yoshihiro; Akita, Wataru; Kuyama, Tamaki; Takada, Shigeru; Asai, Tomoki; Kuwahara, Michio; Sasaki, Sei; Tsukamoto, Yusuke // Nephrology Dialysis Transplantation;Jan2012, Vol. 27 Issue 1, p345 

    Background. In chronic kidney disease stage 5D, diagnostic usefulness of bone mineral density (BMD) in predicting fracture has not been established because of variable results in previous studies. The reason for this may be the heterogeneity of underlying pathogenesis of the fracture. Methods....

  • Mineral and Bone Metabolism Disorders in Minority Incident ESRD Patients in an Inner-City Hemodialysis Unit. Goel, Narender; Pokharna, Hiren; Abramowitz, Matthew K.; Gnanasekaran, Isaiarasi // Einstein Journal of Biology & Medicine;2014/2015, Vol. 30 Issue 1/2, p16 

    Background: Chronic kidney disease (CKD) predisposes patients to mineral and bone metabolism disorder (CKDMBD), which is a well-known risk factor for increased mortality. Because Medical Evidence Form 2728 from the Centers for Medicare and Medicaid Services for incident end-stage renal disease...

  • The parathyroid polyhormone hypothesis revisited. Nemeth, E F // Kidney International Supplement;Jul2006, Issue 102, pS22 

    The parathyroid polyhormone hypothesis holds that peptides derived from the metabolism of parathyroid hormone (PTH) (so-called C-terminal fragments) are themselves biologically active and that their effects are mediated by a novel ‘C-terminal receptor.’ The evidence supporting these...

  • The role of Fibroblast Growth Factor 23 in chronic kidney disease-mineral and bone disorder. Diniz, Hugo; Frazão, João M. // Nefrologia;2013, Vol. 33 Issue 6, p835 

    Fibroblast Growth Factor 23 (FGF-23) is a bone-derived hormone involved in the regulation of phosphate homeostasis. FGF-23 levels are extremely elevated in Chronic Kidney Disease (CKD) and there is evidence supporting the role of this hormone in the pathogenesis of Chronic Kidney Disease-Mineral...

  • 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Coen, Giorgio; Mantella, Daniela; Manni, Micaela; Balducci, Alessandro; Nofroni, Italo; Sardella, Daniela; Ballanti, Paola; Bonucci, Ermanno // Kidney International;Oct2005, Vol. 68 Issue 4, p1840 

    Background: The importance of 25-hydroxyvitamin D (25-OHD) serum levels in hemodialysis chronic renal failure has not been so far histologically evaluated. Information still lacking relate to the effect of 25-OHD deficiency on serum parathyroid hormone (PTH) levels and on bone and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics